MIKROLATEST® BP kits are antibiotic susceptibility testing (AST) panels based on bacterial growth in breakpoint concentrations of defined antibiotics. Breakpoints refer to standards of European Committee for Antimicrobial Susceptibility Testing – EUCAST issued in January 2011. Most of the antibiotics are represented by two (in exceptional cases one or three) breakpoint concentrations which enable interpretation to three categories: sensitive, intermediate or resistant.

Microorganism is defined as sensitive by a level of antimicrobial activity associated with a high probability of therapeutic success, Microorganism is defined as intermediate by a level of antimicrobial activity associated with uncertain therapeutic effect, Microorganism is defined as resistant by a level of antimicrobial activity associated with a high probability of therapeutic failure.

In each test system there is a growth control.